Current and novel antibiotics against resistant Gram-positive bacteria - Wikidata - awgldk - TriplyDB

Current and novel antibiotics against resistant Gram-positive bacteria

Current and novel antibiotics against resistant Gram-positive bacteria

http://www.wikidata.org/entity/Q35026521

about

Antibacterial efficacy testing of a bioelectric wound dressing against clinical wound pathogens Healthcare-associated infections, infection control and the potential of new antibiotics in development in the USA [Resistance to "last resort" antibiotics in Gram-positive cocci: The post-vancomycin era].rplC T460C identified as a dominant mutation in linezolid-resistant Mycobacterium tuberculosis strains.Optimizing the detection of methicillin-resistant Staphylococcus aureus with elevated vancomycin minimum inhibitory concentrations within the susceptible range.β-Lactam antimicrobials: what have you done for me lately?Emerging drugs on methicillin-resistant Staphylococcus aureus.Insights into the mechanism of inhibition of novel bacterial topoisomerase inhibitors from characterization of resistant mutants of Staphylococcus aureus.Orthosiphon stamineus protects Caenorhabditis elegans against Staphylococcus aureus infection through immunomodulation In vitro activities of three new dihydrofolate reductase inhibitors against clinical isolates of gram-positive bacteria.

P2860

Q24595714-FDBCA6FF-1204-4F72-A9DF-6ABA2D89EF2F Q26995305-67A41D2E-AE87-43DA-A0C1-6308C6698887 Q35619094-6C65FD2C-F861-4130-9622-77FFCFFAC355 Q35941267-508017C0-1F4E-41A4-8252-8965F4CFF783 Q36981191-F3D05258-5638-4FF4-8748-1BD920670F2D Q38076453-65406A7E-A9CF-4CD4-987D-FF519CA1E11B Q38121142-B58D1B9E-DA14-47C8-BAFC-3D930B18F8DF Q40833065-4F6BDD35-92A6-4A41-B469-D8D6F9265D01 Q42175755-B8049FFE-1BA3-4515-9217-366E81CE1080 Q42612064-013FEB6B-7EAA-4423-ABAB-2768F285A3E1

P2860

Current and novel antibiotics against resistant Gram-positive bacteria

http://www.wikidata.org/entity/Q35026521

description

2008 nî lūn-bûn

@nan

2008 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Current and novel antibiotics against resistant Gram-positive bacteria

@ast

Current and novel antibiotics against resistant Gram-positive bacteria

@en

type

label

Current and novel antibiotics against resistant Gram-positive bacteria

@ast

Current and novel antibiotics against resistant Gram-positive bacteria

@en

prefLabel

Current and novel antibiotics against resistant Gram-positive bacteria

@ast

Current and novel antibiotics against resistant Gram-positive bacteria

@en

P1433

Q35026521-CF74BA0D-2373-439F-914F-401FAF06458D

P1476

Q35026521-000298D5-FFFE-4FFE-B693-061CC601D5A1

P2093

Q35026521-0BA84A92-6F1A-42E0-9032-929B7F552683

Q35026521-90AFBCE1-5AA3-4A41-AD6F-75B83826A0E9

P2860

Q35026521-013843CC-52F8-44B0-8B5F-436965FE99F0

Q35026521-01AE8954-87E6-40DE-93E4-F527FAA8617D

Q35026521-0407EAFE-B30F-4539-95BB-0B0B80478F44

Q35026521-04C40A97-AA5D-4308-84BB-AF7ABC6152C6

Q35026521-07A70BF6-F464-46B8-A7F6-8368EEE469D2

Q35026521-0B655C56-F5A4-4143-A24F-83CB8417E909

Q35026521-0C03A800-1C72-4806-9612-7290C2B5C7C5

Q35026521-0CF20F7E-A9A8-4011-9B77-A6F3428AE8C8

Q35026521-0E801C6F-EDA6-4B33-8089-748F768312B8

Q35026521-0EF2FF6E-71F6-4980-8465-674796E5447F

P304

Q35026521-55B88B63-C169-4A29-8814-53CA1BA87D48

P31

Q35026521-35C0D6DD-F3D2-4979-A0BC-6D6945BC90E1

P356

Q35026521-DB04552A-A909-4D61-BBCF-E3EF09661C4A

P407

Q35026521-BA142769-4DC4-422C-B06A-328A385D0B73

P478

Q35026521-F2C63497-3694-45E5-9AD8-CF7539B819F9

P50

Q35026521-39310A4E-0AB0-4EF6-AA55-3E60B82B6DE7

P577

Q35026521-86213A18-C8F7-4029-90BB-8EE77C4BDDF3

P698

Q35026521-E67A74CE-79FF-47F6-9DF6-AC592AE3A300

P921

Q35026521-F32BBA37-216E-4C62-9B9E-2C9A43C6923D

P932

Q35026521-D195F29A-93CB-4580-A433-6CB8C636BA27

P356

P1433

Infection and Drug Resistance

P1476

Current and novel antibiotics against resistant Gram-positive bacteria

@en

P2093

Federico Perez

http://www.w3.org/2001/XMLSchema#string

Robert A Salata

http://www.w3.org/2001/XMLSchema#string

P2860

Guidelines for the Management of Adults with Hospital-acquired, Ventilator-associated, and Healthcare-associated Pneumonia

Good clinical outcomes but high rates of adverse reactions during linezolid therapy for serious infections: a proposed protocol for monitoring therapy in complex patients.

Telavancin, a multifunctional lipoglycopeptide, disrupts both cell wall synthesis and cell membrane integrity in methicillin-resistant Staphylococcus aureus

Community-acquired methicillin-resistant Staphylococcus aureus carrying Panton-Valentine leukocidin genes: worldwide emergence

The life and times of the Enterococcus

Phase 2 study of ceftaroline versus standard therapy in treatment of complicated skin and skin structure infections

Tigecycline: first of a new class of antimicrobial agents

Tigecycline: what is it, and where should it be used?

Is Panton-Valentine leukocidin the major virulence determinant in community-associated methicillin-resistant Staphylococcus aureus disease?

Vancomycin resistance in gram-positive cocci

P304

27-44

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/IDR.S3545

http://www.w3.org/2001/XMLSchema#string

P407

P478

1

http://www.w3.org/2001/XMLSchema#string

P50

Robert A Bonomo

P577

2008-09-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21694878

http://www.w3.org/2001/XMLSchema#string

P921

Gram-positive bacteria

P932

3108725

http://www.w3.org/2001/XMLSchema#string